Results 201 to 210 of about 4,976,171 (334)

Somaclonal variability of Ungernia victoris: the necessity of comprehensive genetic analysis [PDF]

open access: diamond, 2008
О. M. Bublyk   +3 more
openalex   +1 more source

Modeling hepatic fibrosis in TP53 knockout iPSC‐derived human liver organoids

open access: yesMolecular Oncology, EarlyView.
This study developed iPSC‐derived human liver organoids with TP53 gene knockout to model human liver fibrosis. These organoids showed elevated myofibroblast activation, early disease markers, and advanced fibrotic hallmarks. The use of profibrotic differentiation medium further amplified the fibrotic signature seen in the organoids.
Mustafa Karabicici   +8 more
wiley   +1 more source

Advanced biometrical strategies for genetic analysis and heterosis assessment in maize germplasm. [PDF]

open access: yesBMC Plant Biol
Jan MF   +7 more
europepmc   +1 more source

Genetic diversity analysis of chicken breeds of India

open access: green, 2006
M. S. Tantia   +4 more
openalex   +1 more source

CYP21A2mutation update: Comprehensive analysis of databases and published genetic variants

open access: green, 2017
Leandro Simonetti   +9 more
openalex   +2 more sources

PYCR1 inhibition in bone marrow stromal cells enhances bortezomib sensitivity in multiple myeloma cells by altering their metabolism

open access: yesMolecular Oncology, EarlyView.
This study investigated how PYCR1 inhibition in bone marrow stromal cells (BMSCs) indirectly affects multiple myeloma (MM) cell metabolism and viability. Culturing MM cells in conditioned medium from PYCR1‐silenced BMSCs impaired oxidative phosphorylation and increased sensitivity to bortezomib.
Inge Oudaert   +13 more
wiley   +1 more source

Clinical features and genetic analysis of A20 haploinsufficiency. [PDF]

open access: yesOrphanet J Rare Dis
Xue F   +7 more
europepmc   +1 more source

Generation and Analysis of Genetically Defined Liver Carcinomas Derived from Bipotential Liver Progenitors [PDF]

open access: bronze, 2005
Lars Zender   +8 more
openalex   +1 more source

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy